Sort
8,912 grants matching “sars cov 2”
Tuberculosis Imaging Program
$2,783,766Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
NIEHS Cryo-EM Core Facility
$2,781,802Mario Borgnia · National Institute Of Environmental Health Sciences · ZIC · FY2023 · ES
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross
$2,769,729Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2019 · AI
Research Resources and Workforce Development for the Rocky Mountain Regional Biocontainment Laboratory at Colorado State University
$2,763,138Karen Marie Dobos · Colorado State University · UC7 · FY2025 · AI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
$2,759,348William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Unravelling immunoregulatory circuits of tissue inflammation
$2,757,763Behdad Afzali · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Socioeconomic and Epidemiological Drivers of Pathogen Dynamics in Wildlife Trade Networks
$2,755,617Matthew J Gray · University Of Tennessee Institute Of Agriculture · · FY2022 · BIO
Administrative Core
$2,752,644Clifford J Rosen · Mainehealth · U54 · FY2023 · GM
Northern New England Clinical and Translational Research Network
$2,752,644Clifford J Rosen · Mainehealth · U54 · FY2023 · GM
Research Resources and Workforce Development for the Rocky Mountain Regional Biocontainment Laboratory at Colorado State University
$2,751,527Karen Marie Dobos · Colorado State University · UC7 · FY2023 · AI
IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases
$2,750,000Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2023 · IP
IP21-002, New Vaccine Surveillance Network
$2,750,000John V Williams · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · IP
IP21-002, Surveillance for Vaccine Preventable Disease in Children
$2,750,000Julie Anne Boom · Baylor College Of Medicine · U01 · FY2023 · IP
IP21-002, Enhanced Surveillance Network for Enteric and Respiratory Viruses in Children: Assessing Disease Burden, Natural History, and Vaccine Effectiveness
$2,750,000Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2023 · IP
IP21-002 US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$2,749,997Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2023 · IP
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$2,749,996Rangaraj Selvarangan · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2023 · IP
IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses
$2,749,994Janet A Englund · Seattle Children'S Hospital · U01 · FY2023 · IP
Sleep and Neurodevelopment Service
$2,739,460Ashura Buckley · National Institute Of Mental Health · ZIA · FY2024 · MH
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross
$2,727,484Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2018 · AI
Development of a handheld rapid air sensing system to monitor and quantify SARS-CoV-2 in aerosols in real-time
$2,723,214Ricardo Mancebo · Genendeavor, Llc · R01 · FY2021 · DE
The role of senescent cells in dysregulating immune responses and pathogen control
$2,723,166Stephen C Jameson · University Of Minnesota · P01 · FY2024 · AI
Thymic and Peripheral Aspects of T Cell Aging and Rejuvenation
$2,712,996Janko Nikolich-Zugich · University Of Arizona · P01 · FY2023 · AG
The role of senescent cells in dysregulating immune responses and pathogen control
$2,709,110Stephen C Jameson · University Of Minnesota · P01 · FY2025 · AI
Research Project 1: Discovery and dissection of virus-host interactions and pathogenetic mechanisms
$2,708,082Kartik Chandran · Albert Einstein College Of Medicine · U19 · FY2024 · AI
Framingham Project/Levy
$2,703,246Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL